+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Soft Tissue Allograft Market (2023-2028) by Type, Applications, End-Users, and Geography, Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis

  • PDF Icon


  • 208 Pages
  • January 2023
  • Region: Global
  • Infogence Global Research
  • ID: 5749032

According to clinical trials.gov, 46 studies on soft tissue allografts had been completed as of March 15, 2020

The Global Soft Tissue Allograft Market is estimated to be USD 5.84 Bn in 2023 and is expected to reach USD 8.12 Bn by 2028, growing at a CAGR of 6.82%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Soft Tissue Allograft Market is segmented based on Type, Applications, End-Users, and Geography
  • By Type, the market is classified into Cartilage Allograft, Tendon Allograft, Meniscus Allograft, and Dental Allograft.
  • By Applications, the market is classified into Orthopedic, Dentistry, and Wound Care.
  • By End-Users, the market is classified into Hospitals, Aesthetic Centers, Orthopedic Clinics, and Dental Clinics.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Arthrex, Inc., Becton, Dickinson, and Co., Medtronic PLC, Smith & Nephew PLC, Stryker Corp., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Soft Tissue Allograft Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Soft Tissue Allograft Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Soft Tissue Allograft Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Soft Tissue Allograft Market

What is the estimated value of the Global Soft Tissue Allograft Market?

The Global Soft Tissue Allograft Market was estimated to be valued at $5.84 Billion in 2023.

What is the growth rate of the Global Soft Tissue Allograft Market?

The growth rate of the Global Soft Tissue Allograft Market is 6.8%, with an estimated value of $8.12 Billion by 2028.

What is the forecasted size of the Global Soft Tissue Allograft Market?

The Global Soft Tissue Allograft Market is estimated to be worth $8.12 Billion by 2028.

Who are the key companies in the Global Soft Tissue Allograft Market?

Key companies in the Global Soft Tissue Allograft Market include Abbvie inc. (Allergan), Acera Surgical, Inc., AlonSource Group, Arthrex, Inc., Becton, Dickinson, and Co., BioStem Technologies, Inc., Bone Bank Allografts, Conmed Corp., Direct Biologics and Institut Straumann AG.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook

4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Demand for Soft Tissue Allografts in Athletics and Other Sports
4.1.2 Growing Cases of Orthopedics and Dentistry Related to Aging
4.1.3 Increasing focus of Soft Tissue Allografts Companies on Brand Protection
4.2 Restraints
4.2.1 High Cost Associated with Implementation of Predictive Analysis
4.2.2 Complicated Reimbursement and Regulatory Policies
4.3 Opportunities
4.3.1 Advancements in Soft Tissue Replacement
4.4 Challenges
4.4.1 Presence of Ambiguous Regulatory Framework

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis

6 Global Soft Tissue Allograft Market, By Type
6.1 Introduction
6.2 Cartilage Allograft
6.3 Tendon Allograft
6.4 Meniscus Allograft
6.5 Dental Allograft

7 Global Soft Tissue Allograft Market, By Applications
7.1 Introduction
7.2 Orthopedic
7.3 Dentistry
7.4 Wound Care

8 Global Soft Tissue Allograft Market, By End-Users
8.1 Introduction
8.2 Hospitals
8.3 Aesthetic Centers
8.4 Orthopedic Clinics
8.5 Dental Clinics

9 Americas' Soft Tissue Allograft Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas

10 Europe's Soft Tissue Allograft Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe

11 Middle East and Africa's Soft Tissue Allograft Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA

12 APAC's Soft Tissue Allograft Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific

13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements

14 Company Profiles
14.1 Abbvie inc. (Allergan)
14.2 Acera Surgical, Inc.
14.3 AlonSource Group
14.4 Arthrex, Inc.
14.5 Becton, Dickinson, and Co.
14.6 BioStem Technologies, Inc.
14.7 Bone Bank Allografts
14.8 Conmed Corp.
14.9 Direct Biologics
14.10 Institut Straumann AG
14.11 Integra LifeSciences Corp.
14.12 Johnson & Johnson
14.13 Lattice Biologics Ltd.
14.14 Medtronic PLC
14.15 MiMedx Group
14.16 Misonix, Inc.
14.17 Ortho Regenerative Technologies, Inc.
14.18 Smith & Nephew PLC
14.19 Stryker Corp.
14.20 Xtant Medical Holdings, Inc.
14.21 Zimmer Biomet

15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Abbvie inc. (Allergan)
  • Acera Surgical, Inc.
  • AlonSource Group
  • Arthrex, Inc.
  • Becton, Dickinson, and Co.
  • BioStem Technologies, Inc.
  • Bone Bank Allografts
  • Conmed Corp.
  • Direct Biologics
  • Institut Straumann AG
  • Integra LifeSciences Corp.
  • Johnson & Johnson
  • Lattice Biologics Ltd.
  • Medtronic PLC
  • MiMedx Group
  • Misonix, Inc.
  • Ortho Regenerative Technologies, Inc.
  • Smith & Nephew PLC
  • Stryker Corp.
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet